Tariel Abdilazimovich Atabekov

Dr. Tariel Abdilazimovich Atabekov

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2022 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBRoman E. Batalov
Roman E. Batalov
TRT. Yu. Rebrova
T. Yu. Rebrova
SKSergey Krivolapov
Sergey Krivolapov
EMElvira Muslimova
Elvira Muslimova
SPSergey Popov
Sergey Popov

Verified
Journal Article
Open access
PDF file
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBRoman Batalov
Roman Batalov
EAEvgenii A. Archakov
Evgenii A. Archakov
ISIrina Silivanova
Irina Silivanova
MKMikhail Khlynin
Mikhail Khlynin
SPSergey Popov
Sergey Popov
Background/Objectives: Atrial fibrillation (AF) is a prevalent arrhythmia that significantly complicates the management of heart failure (HF) patients, particularly those who have implantable cardioverter–defibrillators (ICDs). The interplay between AF and inappropriate ICD therapy poses a critical challenge in optimizing patient outcomes, as inappropriate shocks can lead to increased morbidity, psychological distress, and a reduced quality of life. We aimed to explore the various clinical and demographic predictors of AF in HF patients with indications for ICD implantation. Methods: This study included 122 patients who were indicated for ICD implantation and had undergone transthoracic echocardiography (TE). We evaluated the relationships between clinical and demographic factors and the occurrence of AF, which was recorded either before ICD implantation or during the follow-up period afterward. From our findings, we established predictors and a risk model for AF. Results: Out of 122 HF patients with ICDs, 52 (42.6%) experienced an episode of AF either prior to ICD implantation or during a follow-up period of 20.5 [6.0; 53.0] months, as recorded by the ICDs’ endogram. Patients with AF were older compared to those without AF (p < 0.001). Additionally, they exhibited a higher left ventricular early diastolic filling rate (LVE) (p = 0.006) and a greater left atrial index (LAI) (p = 0.002). These three factors—age, LVE and LAI—were found to be independently associated with AF in both univariable and multivariable logistic regression analyses. The final model, including age, LVE, and LAI, showed a good discrimination capability with an AUC of 0.775. At a cutoff value of >0.47, the model achieved a sensitivity of 67.3% and a specificity of 77.2% in identifying HF patients with ICDs at risk for AF. Conclusions: This study found that 42.6% of HF patients with ICDs experienced AF, with older age, higher LVE, and greater LAI identified as significant predictors.

14 May 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBR. E. Batalov
R. E. Batalov
SSSvetlana Ivanovna Sazonova
Svetlana Ivanovna Sazonova
AGAnna Gusakova
Anna Gusakova
SKSergey Krivolapov
Sergey Krivolapov
SPSergey Popov
Sergey Popov
Aim. To assess the role of stimulating growth factor 2 (ST-2) and galectin-3 in predicting the ventricular tachyarrhythmias (VTA) in patients with coronary artery disease (CAD) and left ventricular ejection fraction (LVEF) <35%.Material and methods. The study included 40 patients (men, 36 (90,0%); median age, 64,5 [57,5; 68,5] years) with CAD, NYHA class IIIII heart failure, LVEF 22,48 ng/ml (p=0,02) and galectin-3 >10,95 ng/ml (p=0,009) corresponded to appropriate ICD discharge. Multivariate ROC analysis demonstrated that the only independent predictor of VTA was ST-2 elevation (odds ratio, 1,11; 95% CI, 1,01-1,21; p=0,023).Conclusion. An increase in the concentration of both ST-2 >22,48 ng/ml and galectin-3 >10,95 ng/ml had a high predictive value in assessing the VTA risk in patients with ischemic cardiomyopathy. In multivariate analysis, an increase in ST-2 >22,48 ng/ml was an independent predictor of VTA.

25 December 2019 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBR. E. Batalov
R. E. Batalov
SKS. N. Krivolapov
S. N. Krivolapov
MKMikhail Khlynin
Mikhail Khlynin
SPSergey Popov
Sergey Popov
Снижение вариабельности сердечного ритма как неинвазивный предиктор развития желудочковых тахиаритмий у пациентов с ишемической болезнью сердца

14 January 2024 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
VKViacheslav Korepanov
Viacheslav Korepanov
TRT. Yu. Rebrova
T. Yu. Rebrova
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
SAS. A. Afanasiev
S. A. Afanasiev
Introduction. Coronary artery disease (CAD) continues to be the most common pathology in the structure of cardiovascular diseases over the past decades, both in Russia and around the world. In the normal condition, the mitochondria of all body cells have the same function capabilities due to the carriage of the same genome. Therefore, it is possible to assess the respiration activity of cardiomyocyte mitochondria by the respiration of mitochondria from peripheral blood leukocytes.Aim: To compare respiratory activity of mitochondria of peripheral blood leukocytes in patients diagnosed with coronary artery disease and coronary artery disease with developed cardiac rhythm disorders (CRD).Material and methods. The studied groups included 45 patients with CAD without CRD and 39 patients with CAD complicated by CRD. Mitochondria were isolated from peripheral blood leukocytes by differential centrifugation. The rate of oxygen loss in pyruvate-malate and succinate incubation buffers was measured when isolated mitochondria were introduced, as well as when palmitic acid was added to the medium. Oxygen consumption rate for the V3 (active phosphorylating) and V4 (nonphosphorylating) metabolic sates was determined, and on their basis respiratory control coefficient was calculating using the formula V3/V4. Statistical data processing was carried out using STATISTICA 13.0 software.Results. Oxygen consumption rate in mitochondria of patients with uncomplicated CAD and CAD with CRD had no significant differences in either pyruvate-malate or succinate buffers. When palmitic acid was added to the incubation medium, the mitochondria of CAD patients without CRD significantly increased oxygen consumption rate in both incubation media. Mitochondria of CAD patients with CRD did not change oxygen consumption rate in both metabolic states after the addition of palmitic acid in incubation media.Conclusion. On the basis of the data obtained, it can be concluded that the function capabilities of mitochondria in the complicated course of CAD has been exhausted, which manifests itself in the inability to increase ATP synthesis in response to the introduction of additional substrates.

1 March 2018 in EP Europace
Verified
Closed access
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
SSS Sazonova
S Sazonova
RBR Batalov
R Batalov
MKM Khlynin
M Khlynin
ASA Shvarzman
A Shvarzman
SPS Popov
S Popov
Introduction: It’s well known, that it’s necessary to choose the correct place for the defibrillating electrode (DE) during the ICD implantation procedure. DE implantation using basic criteria aren’t taken into account the myocardial perfusion and sympathetic activity disorders. That may lead to the rise of the pacing threshold (PT), drop of the ventricular signal amplitude (VSA) and finally to inappropriate shocks. So it’s necessary to find new criteria that can determine the most suitable place for DE implantation.